These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28849458)

  • 1. Taurine-Carbohydrate Derivative Stimulates Fibrillogenesis of Amyloid-β and Reduce Alzheimer-Like Behaviors.
    Kim HY; Yang SH; Yoon J; Jang H; Baek S; Shin J; Kim SH; Kim Y
    Adv Exp Med Biol; 2017; 975 Pt 1():225-232. PubMed ID: 28849458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurine Directly Binds to Oligomeric Amyloid-β and Recovers Cognitive Deficits in Alzheimer Model Mice.
    Jang H; Lee S; Choi SL; Kim HY; Baek S; Kim Y
    Adv Exp Med Biol; 2017; 975 Pt 1():233-241. PubMed ID: 28849459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer's Mice with Full-blown Pathology.
    Schemmert S; Schartmann E; Zafiu C; Kass B; Hartwig S; Lehr S; Bannach O; Langen KJ; Shah NJ; Kutzsche J; Willuweit A; Willbold D
    Mol Neurobiol; 2019 Mar; 56(3):2211-2223. PubMed ID: 30003517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ oligomers trigger and accelerate Aβ seeding.
    Katzmarski N; Ziegler-Waldkirch S; Scheffler N; Witt C; Abou-Ajram C; Nuscher B; Prinz M; Haass C; Meyer-Luehmann M
    Brain Pathol; 2020 Jan; 30(1):36-45. PubMed ID: 31099449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain.
    Hey JA; Kocis P; Hort J; Abushakra S; Power A; Vyhnálek M; Yu JY; Tolar M
    CNS Drugs; 2018 Sep; 32(9):849-861. PubMed ID: 30076539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginnalin A Inhibits Aggregation, Reverses Fibrillogenesis, and Alleviates Cytotoxicity of Amyloid β(1-42).
    Fan Q; Liu Y; Wang X; Zhang Z; Fu Y; Liu L; Wang P; Ma H; Ma H; Seeram NP; Zheng J; Zhou F
    ACS Chem Neurosci; 2020 Feb; 11(4):638-647. PubMed ID: 31967782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
    Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
    J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ.
    Meilandt WJ; Maloney JA; Imperio J; Lalehzadeh G; Earr T; Crowell S; Bainbridge TW; Lu Y; Ernst JA; Fuji RN; Atwal JK
    Alzheimers Res Ther; 2019 Dec; 11(1):97. PubMed ID: 31787113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.
    Cerpa W; Dinamarca MC; Inestrosa NC
    Curr Alzheimer Res; 2008 Jun; 5(3):233-43. PubMed ID: 18537540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid beta proteins in vitro and in vivo.
    Fujiwara H; Tabuchi M; Yamaguchi T; Iwasaki K; Furukawa K; Sekiguchi K; Ikarashi Y; Kudo Y; Higuchi M; Saido TC; Maeda S; Takashima A; Hara M; Yaegashi N; Kase Y; Arai H
    J Neurochem; 2009 Jun; 109(6):1648-57. PubMed ID: 19457098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
    Fawver JN; Ghiwot Y; Koola C; Carrera W; Rodriguez-Rivera J; Hernandez C; Dineley KT; Kong Y; Li J; Jhamandas J; Perry G; Murray IV
    Curr Alzheimer Res; 2014; 11(10):928-40. PubMed ID: 25387341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Uranyl (UO
    Berntsson E; Vosough F; Noormägi A; Padari K; Asplund F; Gielnik M; Paul S; Jarvet J; Tõugu V; Roos PM; Kozak M; Gräslund A; Barth A; Pooga M; Palumaa P; Wärmländer SKTS
    ACS Chem Neurosci; 2023 Aug; 14(15):2618-2633. PubMed ID: 37487115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid binding ligands as Alzheimer's disease therapies.
    Lee VM
    Neurobiol Aging; 2002; 23(6):1039-42. PubMed ID: 12470800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease as oligomeropathy.
    Ono K
    Neurochem Int; 2018 Oct; 119():57-70. PubMed ID: 28821400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
    Habchi J; Arosio P; Perni M; Costa AR; Yagi-Utsumi M; Joshi P; Chia S; Cohen SI; Müller MB; Linse S; Nollen EA; Dobson CM; Knowles TP; Vendruscolo M
    Sci Adv; 2016 Feb; 2(2):e1501244. PubMed ID: 26933687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
    Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
    Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.